Socioeconomic outcomes with ribociclib in patients with HR+, HER2-advanced breast cancer (ABC) in UK real-world settings
Hall, P. Howell, Sacha J Venkitaraman, R. Thomson, A. Raja, F. King, J. Michie, C. Khan, S. Brunt, A. M. Gahir, D.
Hall, P.
Howell, Sacha J
Venkitaraman, R.
Thomson, A.
Raja, F.
King, J.
Michie, C.
Khan, S.
Brunt, A. M.
Gahir, D.
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Hall P, Howell S, Venkitaraman R, Thomson A, Raja F, King J, et al. Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2-Advanced Breast Cancer (ABC) in UK Real-world Settings. Breast (Edinburgh, Scotland). 2023 Apr;68:S47-S. PubMed PMID: WOS:001037996400099.